Literature DB >> 7166578

Migration of cultured vascular cells in response to plasma and platelet-derived factors.

L R Bernstein, H Antoniades, B R Zetter.   

Abstract

Phagokinetic migration of cultured vascular cells was tested in response to human platelet-rich serum ('serum') and human platelet-poor plasma serum ('plasma'). The cell types tested included bovine aortic endothelial cells, human umbilical vein endothelial cells, human haemangiomal capillary endothelial cells, bovine adrenal microvascular pericytes, and bovine aortic smooth muscle cells. Human serum stimulated a significant increase in the rate of migration for all five cell types. Human plasma stimulated the endothelial cells to migrate but had no effect on the migration of pericytes or smooth muscle cells. Highly purified platelet-derived growth factor (PDGF) stimulated dose-dependent migration of smooth muscle cells causing a 50% increase in phagokinetic track area relative to controls. Neither pericyte nor endothelial cell migration was stimulated by PDGF. Rabbit antiserum to human PDGF completely blocked the smooth muscle cell migration induced by either 10% serum or 1 ng/ml pure PDGF. Purified platelet factor IV (PF4) stimulated migration of pericytes but not of smooth muscle cells nor endothelial cells. Sheep antiserum to human PF4 completely blocked the pericyte migration induced by either 10% serum or 1 microgram/ml pure PF4. These results indicate that PDGF is the primary factor in serum responsible for the migration of cultured aortic smooth muscle cells and that PF4 is a critical factor required to induce the migration of pericytes. Other factors present in both plasma and serum control the migration of vascular endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7166578     DOI: 10.1242/jcs.56.1.71

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  10 in total

1.  Immortalized CNS pericytes are quiescent smooth muscle actin-negative and pluripotent.

Authors:  Paula Dore-Duffy; Afroza Mehedi; Xueqian Wang; Michael Bradley; Richard Trotter; Alexander Gow
Journal:  Microvasc Res       Date:  2011-04-15       Impact factor: 3.514

2.  Cinematographic analysis of vascular smooth muscle cell interactions with extracellular matrix.

Authors:  M Absher; L Baldor
Journal:  In Vitro Cell Dev Biol       Date:  1991-01

Review 3.  Diverse Applications of Nanomedicine.

Authors:  Beatriz Pelaz; Christoph Alexiou; Ramon A Alvarez-Puebla; Frauke Alves; Anne M Andrews; Sumaira Ashraf; Lajos P Balogh; Laura Ballerini; Alessandra Bestetti; Cornelia Brendel; Susanna Bosi; Monica Carril; Warren C W Chan; Chunying Chen; Xiaodong Chen; Xiaoyuan Chen; Zhen Cheng; Daxiang Cui; Jianzhong Du; Christian Dullin; Alberto Escudero; Neus Feliu; Mingyuan Gao; Michael George; Yury Gogotsi; Arnold Grünweller; Zhongwei Gu; Naomi J Halas; Norbert Hampp; Roland K Hartmann; Mark C Hersam; Patrick Hunziker; Ji Jian; Xingyu Jiang; Philipp Jungebluth; Pranav Kadhiresan; Kazunori Kataoka; Ali Khademhosseini; Jindřich Kopeček; Nicholas A Kotov; Harald F Krug; Dong Soo Lee; Claus-Michael Lehr; Kam W Leong; Xing-Jie Liang; Mei Ling Lim; Luis M Liz-Marzán; Xiaowei Ma; Paolo Macchiarini; Huan Meng; Helmuth Möhwald; Paul Mulvaney; Andre E Nel; Shuming Nie; Peter Nordlander; Teruo Okano; Jose Oliveira; Tai Hyun Park; Reginald M Penner; Maurizio Prato; Victor Puntes; Vincent M Rotello; Amila Samarakoon; Raymond E Schaak; Youqing Shen; Sebastian Sjöqvist; Andre G Skirtach; Mahmoud G Soliman; Molly M Stevens; Hsing-Wen Sung; Ben Zhong Tang; Rainer Tietze; Buddhisha N Udugama; J Scott VanEpps; Tanja Weil; Paul S Weiss; Itamar Willner; Yuzhou Wu; Lily Yang; Zhao Yue; Qian Zhang; Qiang Zhang; Xian-En Zhang; Yuliang Zhao; Xin Zhou; Wolfgang J Parak
Journal:  ACS Nano       Date:  2017-03-14       Impact factor: 15.881

4.  Plasma binding proteins for platelet-derived growth factor that inhibit its binding to cell-surface receptors.

Authors:  E W Raines; D F Bowen-Pope; R Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

5.  Platelet-derived growth factor in idiopathic pulmonary fibrosis.

Authors:  H N Antoniades; M A Bravo; R E Avila; T Galanopoulos; J Neville-Golden; M Maxwell; M Selman
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

6.  Delivery of sphingosine 1-phosphate from poly(ethylene glycol) hydrogels.

Authors:  Bradley K Wacker; Evan A Scott; Megan M Kaneda; Shannon K Alford; Donald L Elbert
Journal:  Biomacromolecules       Date:  2006-04       Impact factor: 6.988

7.  Effects of platelet derived growth factor (PDGF) on fibronectin (FN) production by human skin and scar fibroblasts.

Authors:  C W Kischer; J Pindur
Journal:  Cytotechnology       Date:  1990-05       Impact factor: 2.058

8.  Induction of c-sis gene expression and synthesis of platelet-derived growth factor in human myeloid leukemia cells during monocytic differentiation.

Authors:  P Pantazis; E Sariban; D Kufe; H N Antoniades
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

9.  Platelet factor 4 mediates vascular smooth muscle cell injury responses.

Authors:  Guanfang Shi; David J Field; Xiaochun Long; Deanne Mickelsen; Kyung-ae Ko; Sara Ture; Vyacheslav A Korshunov; Joseph M Miano; Craig N Morrell
Journal:  Blood       Date:  2013-04-08       Impact factor: 22.113

10.  Polarized secretion of a platelet-derived growth factor-like chemotactic factor by endothelial cells in vitro.

Authors:  H G Zerwes; W Risau
Journal:  J Cell Biol       Date:  1987-11       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.